Nutriband issued CNIPA patent for abuse, misuse deterrent transdermal system

Nutriband (NTRB) has announced that the Chinese National Intellectual Property Administrant has fully issued its patent titled “Abuse and Misuse Deterrent Transdermal System” which is related to the Company’s lead technology AVERSA. The patent underpins 4p Therapeutics’ abuse deterrent transdermal system, AVERSA, which uses taste aversion to address the primary routes of abuse for opioid based transdermal patches. The patent number reflects the issuance of Patent No: ZL 202211158031. The CNIPA issued a prior notice of allowance in September 2024.